{"id":19090,"date":"2022-01-01T00:00:00","date_gmt":"2022-01-01T00:00:00","guid":{"rendered":"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/"},"modified":"2022-01-01T00:00:00","modified_gmt":"2022-01-01T00:00:00","slug":"pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/","title":{"rendered":"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR)."},"content":{"rendered":"<p>BEGO\u00d1A OLIVER MARTOS &#8211; NACIONAL &#8211; INSTITUTO DE SALUD CARLOS III &#8211; 2022<\/p>","protected":false},"excerpt":{"rendered":"<p>BEGO\u00d1A OLIVER MARTOS &#8211; NACIONAL &#8211; INSTITUTO DE SALUD CARLOS III &#8211; 2022<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1510],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR). - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR). - Ibima\" \/>\n<meta property=\"og:description\" content=\"BEGO\u00d1A OLIVER MARTOS - NACIONAL - INSTITUTO DE SALUD CARLOS III - 2022\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-01T00:00:00+00:00\" \/>\n<meta name=\"author\" content=\"prodriguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"prodriguez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/\",\"url\":\"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/\",\"name\":\"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR). - Ibima\",\"isPartOf\":{\"@id\":\"https:\/\/ibima.eu\/es\/#website\"},\"datePublished\":\"2022-01-01T00:00:00+00:00\",\"dateModified\":\"2022-01-01T00:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635\"},\"breadcrumb\":{\"@id\":\"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/ibima.eu\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR).\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ibima.eu\/es\/#website\",\"url\":\"https:\/\/ibima.eu\/es\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ibima.eu\/es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635\",\"name\":\"prodriguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ibima.eu\/es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1438f1fd1109c815d89b9163757252a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1438f1fd1109c815d89b9163757252a6?s=96&d=mm&r=g\",\"caption\":\"prodriguez\"},\"sameAs\":[\"https:\/\/ibima.eu\"],\"url\":\"https:\/\/ibima.eu\/en\/author\/prodriguez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR). - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/","og_locale":"en_GB","og_type":"article","og_title":"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR). - Ibima","og_description":"BEGO\u00d1A OLIVER MARTOS - NACIONAL - INSTITUTO DE SALUD CARLOS III - 2022","og_url":"https:\/\/ibima.eu\/en\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/","og_site_name":"Ibima","article_published_time":"2022-01-01T00:00:00+00:00","author":"prodriguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"prodriguez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/","url":"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/","name":"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR). - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2022-01-01T00:00:00+00:00","dateModified":"2022-01-01T00:00:00+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635"},"breadcrumb":{"@id":"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/pi22-00596-caracterizacion-genetica-y-evaluacion-funcional-de-la-respuesta-de-interferon-tipo-i-en-pacientes-con-encefalitis-anti-receptor-nmda-ifn-nmdar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"PI22-00596 Caracterizaci\u00f3n gen\u00e9tica y evaluaci\u00f3n funcional de la respuesta de interfer\u00f3n tipo I en pacientes con encefalitis anti-receptor NMDA (IFN-NMDAR)."}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/40b410344dd5ad2315bb651e3fbfa635","name":"prodriguez","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1438f1fd1109c815d89b9163757252a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1438f1fd1109c815d89b9163757252a6?s=96&d=mm&r=g","caption":"prodriguez"},"sameAs":["https:\/\/ibima.eu"],"url":"https:\/\/ibima.eu\/en\/author\/prodriguez\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/19090"}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=19090"}],"version-history":[{"count":0,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/19090\/revisions"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=19090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=19090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=19090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}